of the patient's normal visual acuity, symmetric changes, and lack of symptoms, we suspected a metabolic storage disorder. Laboratory test results showed normal levels of ␤-galactosidase, arylsulfatase A, hexosaminidase A and B, and ␤-galactocerebrosidase. However, sialic acid levels were elevated in the urine. Examination results of a skin biopsy specimen revealed a fibroblast ␣-neuraminidase level of 0.5 nmoles/h per milligram of protein (reference range, 15.0-30.0 nmoles/h per milligram of protein). Based on these findings, a diagnosis of sialidosis (mucolipidosis type I) was made.
Comment. Sialidosis (mucolipidosis type I) is a rare inherited lysosomal storage disease characterized by deficiency of ␣-Nacetylneuraminidase (sialidase) in leukocytes and cultured fibroblasts. 1 This results in intracellular storage of excess sialyloligosaccharides and is histologically observed as abnormal vacuolization of various cell types. Two major phenotypes of mucolipidosis exist: type I or the cherry red spot myoclonus syndrome, and a more severe infantile form, type II. Sialidosis has an autosomal recessive pattern of inheritance, and the gene has been localized on chromosome 6p21. 2 It occurs in 1 of every 2 200 000 live births. Patients with type II disease have somatic changes, characterized by coarse facies, hepatolomegaly, bony changes of dysostosis multiplex, and developmental delay. Patients with type II disease usually die within the first 2 years (congenital form) or by the second decade (infantile form) of life.
3 By contrast, patients with type I disease are less severely affected and typically develop symptoms of myoclonic epilepsy, visual problems, and ataxia in the second or the third decade of life. 4 Macular cherry red spots are always present and, therefore, sialidosis should be included in the differential diagnosis of a cherry red macula in this clinical setting. Diagnostic evaluation for a patient with a cherry red spot in the macula not due to arterial occlusion should include a genetic history and an appropriate laboratory workup to confirm the underlying cause.
Conclusions.
We herein present a rare case of a 14-year-old boy with mucolipidosis type I who had cherry red spots in the maculae of both eyes. The patient had minimal symptoms and visual acuity correctable to 20/20 OU. Of interest in this case are the fluorescein angiogram and optical coherence tomogram findings. The fluorescein angiogram shows blocked fluorescence surrounding the fovea throughout the angiogram (eFigure 1). The optical coherence tomogram shows increased reflectivity in the ganglion cell layer corresponding to the blocked fluorescence (eFigure 2). Although pathological confirmation is lacking in this case, a previous autopsy report of a patient with mucolipidosis type I demonstrated diffuse intracytoplasmic accumulation of lipofuscinlike pigment in the cerebral neurons. 5 This leads us to speculate that the ophthalmoscopic changes observed in our patient are due to an accumulation of sialyloligosaccharides in the inner layers of the retina. 
Macular Retinal Detachment in Hallermann-Streiff Syndrome
Hallermann-Streiff syndrome (also known as oculomandibulofacial syndrome) is a rare syndrome chiefly comprising facial and ocular abnor- malities. Cataract and microphthalmos are the most apparent ocular features, but retinal abnormalities may be the primary cause of poor vision.
Report of a Case. A 1-week-old girl of European descent was initially seen with bilateral cataracts. She was small for her 35-week gestational age. She exhibited microcephaly with birdlike facies, natal teeth, sparse fine hair, and long hyperextensible fingers consistent with features of Hallermann-Streiff syndrome (Figure 1) .
Ophthalmologic examination revealed bilateral microphthalmia, horizontal corneal diameters of 6 mm, and bilateral visually significant cataracts preventing view of the ocular fundi. Cataract extractions were performed in this patient at 5 and 6 weeks of age. Indirect ophthalmoscopy revealed bilateral macular serous retinal detachments with horizontal retinal folds through the macula, as well as peripapillary and peripheral retinal pigment epithelial mottling (Figure 2) . Treatment of uveal effusion syndrome by means of scleral surgery was considered but was declined by the parents.
Comment.
Hallermann-Streiff syndrome was first described by Charles Aubry in 1893. 1 François 2 analyzed 22 cases and described 7 essential signs for what he regarded as a new syndrome linked to the various hereditary ectodermal dysplasias. These signs are (1) dyscephalia and birdlike facies, (2) dental abnormalities, (3) proportionate short stature, (4) atrophy of skin (especially on the nose), (5) hypotrichosis, (6) bilateral microphthalmos, and (7) cataract. Most cases of HallermannStreiff syndrome are sporadic.
Autosomal dominant inheritance has been suggested in some cases. The retinal changes we observed were strikingly similar to the original drawing of fundus abnormalities in this syndrome by François. 3 To our knowledge, there is no fundus photograph of a patient with Hallermann-Streiff syndrome in the English-language literature. A fluorescein angiogram (without redfree or color photography) of an exceptional case diagnosed at 11 years of age showed multiple areas of choroidal leakage. 4 
